IRCT20120215009014N445
Not yet recruiting
Phase 3
Evaluating the efficacy of mirtazapine versus sertraline on depression symptoms in patients undergoing hemodialysis: a double-blind randomized clinical trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamedan University of Medical Sciences
- Enrollment
- 54
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age of 18 to 5 years
- •Undergoing hemodialysis for at least 6 months
- •Being literate
- •Suffering from depression
Exclusion Criteria
- •Pregnancy or breastfeeding
- •Receiving anti\-depressant and anti\-anxiety medication in the last 3 months
- •Liver failure
- •Use of drugs or alcohol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Comparison of mirtazapine and citalopram in the treatment of depression in patients with breast cancerMajor Depression, Breast Cancer, Mirtazapine, Citalopram.Malignant neoplasm of breast, major depressionC50 , F32IRCT20220406054440N1Gorgan University of Medical Sciences42
Not yet recruiting
Phase 3
Comparison of shivering in drugs of Mirtazapine , Dexamethasone and Tramadol after spinal anaesthesiaHealth Condition 1: O82- Encounter for cesarean delivery without indicationCTRI/2023/12/060608SRINIVASAN T
Recruiting
Phase 1
The effectiveness of mirtazapine in reducing dependence and the temptation to consume amphetamine and methamphetamine in patientsIRCT20230606058397N1Ahvaz University of Medical Sciences84
Recruiting
Phase 2
Effect of mirtazapine on pruritus in dialysis patientsremic pruritus.Pruritus, unspecifiedL29.9IRCT20120314009297N9Mazandaran University of Medical Sciences60
Completed
Not Applicable
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phaseISRCTN00721331Stanley Medical Research Institute (USA)40